MSFT
Microsoft Corporation
MSFT has the edge over TBCH overall, supported by stronger fundamentals and stronger valuation.
TBCH
Turtle Beach Corporation
TBCH's outlook is improving, though it still trails on the overall score.
MSFT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Healthy | |
| Strong |
MSFT's revenue, profitability, cash flow and balance sheet are all currently healthy.
TBCH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Under pressure | |
| Strong | |
| Weak |
TBCH's cash flow is currently strong, and its revenue is stable, but its profitability and balance sheet are under pressure.
MSFT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 25x | $523 | — |
| Cheap | 27x | $525 | +0.4% |
| Current | 27x | $523 | — |
| Fair | 34x | $652 | +25% |
| Expensive | 37x | $711 | +36% |
Historical ranges are pointers, not guarantees.
MSFT's PE is in its cheap range at 27x. If earnings grow as analysts expect, today's price would be 25x next year's earnings.
TBCH PE Valuation
TBCH has no meaningful PE right now: it lost money over the past year.
MSFT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Moderate | |
| High |
Analysts expect strong earnings and revenue growth for MSFT, with profitability holding steady.
TBCH Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
TBCH has the edge over MSFT on the outlook, with more favorable profitability expectations.
MSFT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $20.79 | +8.6% |
| Q3 2026 | $19.15 | +36% |
| Q2 2026 | $17.95 | +32% |
| Q1 2026 | $16.80 | +30% |
| Q4 2025 | $15.99 | +29% |
| Q3 2025 | $14.06 | +16% |
| Q2 2025 | $13.64 | +16% |
| Q1 2025 | $12.93 | +12% |
| Q4 2024 | $12.41 | +12% |
MSFT has the edge over TBCH on earnings quality, reporting a profit while its opponent remains loss making.
TBCH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.16 | — |
| Q3 2026 | -$0.06 | -107% |
| Q2 2026 | -$0.22 | -123% |
| Q1 2026 | $0.02 | -97% |
| Q4 2025 | $0.77 | -1.3% |
| Q3 2025 | $0.87 | +200% |
| Q2 2025 | $0.95 | +$1.03 |
| Q1 2025 | $0.74 | +$1.40 |
| Q4 2024 | $0.78 | +$1.85 |
TBCH has swung to a loss: it lost $0.06 per share over the past year, after a profit the year before.
MSFT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $92.3B | +19% |
| Q2 2026 | $90B | +18% |
| Q1 2026 | $82.9B | +18% |
| Q4 2025 | $81.3B | +17% |
| Q3 2025 | $77.7B | +18% |
| Q2 2025 | $76.4B | +18% |
| Q1 2025 | $70.1B | +13% |
| Q4 2024 | $69.6B | +12% |
MSFT has the edge over TBCH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 50% | +0.9 points |
| Q2 2026 | 45% | +0.2 points |
| Q1 2026 | 46% | +0.7 points |
| Q4 2025 | 47% | +1.6 points |
| Q3 2025 | 49% | +2.3 points |
| Q2 2025 | 45% | +1.8 points |
| Q1 2025 | 46% | +1.1 points |
| Q4 2024 | 45% | +1.9 points |
MSFT has the edge over TBCH on profitability, with a higher operating margin.
TBCH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $84.7M | +5.3% |
| Q2 2026 | $56.4M | -0.7% |
| Q1 2026 | $42.2M | -34% |
| Q4 2025 | $118.8M | -19% |
| Q3 2025 | $80.5M | -15% |
| Q2 2025 | $56.8M | -26% |
| Q1 2025 | $63.9M | +14% |
| Q4 2024 | $146.1M | +47% |
TBCH's revenue is recovering but still below its 2024 peak: $85M last quarter, up 5.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7% | +0.3 points |
| Q2 2026 | -5.4% | -4.8 points |
| Q1 2026 | -33% | -36 points |
| Q4 2025 | 18% | +1.6 points |
| Q3 2025 | 6.7% | -0.1 points |
| Q2 2025 | -0.6% | +4.8 points |
| Q1 2025 | 2.4% | +13 points |
| Q4 2024 | 16% | +7.6 points |
TBCH's operating margin was 7% last quarter, about level with the same quarter a year ago.
MSFT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $18.6B | -27% |
| Q2 2026 | $19.6B | -23% |
| Q1 2026 | $15.8B | -22% |
| Q4 2025 | $5.9B | -9.3% |
| Q3 2025 | $25.7B | +33% |
| Q2 2025 | $25.6B | +9.6% |
| Q1 2025 | $20.3B | -3.2% |
| Q4 2024 | $6.5B | -29% |
MSFT's free cash flow has been positive every quarter for seven years: $60B over the past year, down 23% from the year before.
TBCH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$7.3M | +$8.5M |
| Q2 2026 | $5.9M | +$9.4M |
| Q1 2026 | $29.1M | -28% |
| Q4 2025 | $13.1M | +2.3% |
| Q3 2025 | -$15.9M | +$8.7M |
| Q2 2025 | -$3.5M | +$10.4M |
| Q1 2025 | $40.3M | +52% |
| Q4 2024 | $12.8M | -32% |
TBCH has the edge over MSFT on cash flow, with more consistent year-over-year improvement.
MSFT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -7M shares |
| 1 year | -0.3% | -20M shares |
| 3 years | -0.2% | -16M shares |
| 5 years | -1.6% | -121M shares |
| Available history | -3.2% | -245M shares |
MSFT has 7.4B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $4.4B |
| Q2 2026 | $4.6B |
| Q1 2026 | $4.6B |
| Q4 2025 | $7.4B |
| Q3 2025 | $5.7B |
| Q2 2025 | $4.5B |
| Q1 2025 | $4.8B |
| Q4 2024 | $5B |
MSFT spent $21B buying back its own shares over the past year, up 5.2% from the year before.
TBCH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -5.1% | -985K shares |
| 1 year | -11% | -2.2M shares |
| 3 years | +4.9% | +852K shares |
| 5 years | -0.8% | -138K shares |
| Available history | +16% | +2.5M shares |
TBCH has the edge over MSFT on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $25M |
| Q1 2026 | $2.2M |
| Q4 2025 | $2M |
| Q3 2025 | $10.3M |
| Q2 2025 | $5M |
| Q1 2025 | $1.8M |
| Q4 2024 | $2.4M |
TBCH spent $29M buying back its own shares over the past year, up 50% from the year before.
MSFT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.1x | Very low |
| Q2 2026 | 0.1x | Very low |
MSFT has the edge over TBCH on leverage, with a lower net debt burden relative to earnings.
TBCH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.2x | High |
| Q2 2026 | 4.7x | High |
| Q1 2026 | 2.5x | Moderate |
| Q4 2025 | 1.2x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 0.8x | Very low |
| Q1 2025 | 1.1x | Healthy |
| Q4 2024 | 1.4x | Healthy |
TBCH's net debt is about 5.2 years of its operating earnings (EBITDA), up from 1.3 years a year ago.
MSFT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 62.1 | Neutral |
| Stochastic | 68.0 | Neutral |
MSFT's weekly RSI is 62 (neutral) and its Stochastic is 68 (neutral).
TBCH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.8 | Neutral |
| Stochastic | 76.0 | Neutral |
TBCH's weekly RSI is 64 (neutral) and its Stochastic is 76 (neutral).
MSFT PE vs Technology Sector
| Metric | MSFT | Sector median | Relative |
|---|---|---|---|
| PE | 27x | 28x | 2% below |
| PE % | 16 | 35 | 19 pts below |
MSFT is trading at 27x earnings, in line with the Technology sector's median of 28x.
TBCH PE vs Technology Sector
| Metric | TBCH | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 28x | — |
TBCH has no meaningful PE right now: it lost money over the past year.
MSFT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $524.7 | 0.3% below |
| 20 week MA | $484.8 | 7.9% above |
| 50 week MA | $446.9 | 17% above |
| 100 week MA | $453.8 | 15% above |
| 200 week MA | $411.5 | 27% above |
MSFT's trend is up, with a small recent dip: it's below only its 8-week average, and 27% above its 200-week average.
TBCH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $14.9 | 11% above |
| 20 week MA | $13.6 | 21% above |
| 50 week MA | $12.9 | 28% above |
| 100 week MA | $13.8 | 19% above |
| 200 week MA | $13.1 | 26% above |
TBCH has the edge over MSFT on trend strength, trading above more of its moving averages.
MSFT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $159.0 | $222.8 | +40% |
| 2021 | $222.8 | $334.7 | +50% |
| 2022 | $334.7 | $238.7 | -29% |
| 2023 | $238.7 | $376.0 | +58% |
| 2024 | $376.0 | $430.5 | +14% |
| 2025 | $430.5 | $487.7 | +13% |
| 2026 YTD | $487.7 | $523.0 | +7.2% |
MSFT has finished higher in five of the last six years, two of them by more than 50%. It's up 7.2% so far in 2026.
TBCH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.91 | $24.7 | +178% |
| 2021 | $24.7 | $24.5 | -1.1% |
| 2022 | $24.5 | $6.99 | -71% |
| 2023 | $6.99 | $11.0 | +57% |
| 2024 | $11.0 | $16.9 | +55% |
| 2025 | $16.9 | $14.2 | -16% |
| 2026 YTD | $14.2 | $16.5 | +17% |
TBCH has the edge over MSFT on returns for 2026, with the stronger performance.